Richard Markus's most recent trade in Arcus Biosciences Inc was a trade of 305,328 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 10, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Arcus Biosciences Inc | Richard Markus | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 305,328 | 305,328 | - | - | Stock Option (right to buy) | |
Arcus Biosciences Inc | Richard Markus | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 75,193 | 75,193 (0%) | 0% | 0 | Common Stock |